Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status

This study was designed to retrospectively evaluate the efficacy and safety of modified FOLFOX-6 regimen in advanced gastric cancer (AGC) patients with poor performance status (PS). From January 2005 to August 2010, 23 AGC patients with poor PS who received mFOLFOX-6 as first-line chemotherapy were...

Full description

Saved in:
Bibliographic Details
Main Authors: KIM, HYEONG SU, KIM, JUNG HAN, KIM, HEE JUN, JANG, HYUN JOO, KIM, JIN BAE, KIM, JI WON, JUNG, SO YOUNG, KIM, BYUNG CHUN, YANG, DAE HYUN, PARK, SOAH, KIM, KEONG JU, LEE, SOON IL, ZANG, DAE YOUNG
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2012
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362383/
https://ncbi.nlm.nih.gov/pubmed/22740925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.496
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items